Manufacturing of convalescent plasma of COVID-19 patients: Aspects of quality.

Manufacturing of convalescent plasma of COVID-19 patients: Aspects of quality.

The ongoing coronavirus disease 2019 (COVID-19) pandemic emerged in December 2019. Convalescent plasma represents a promising COVID-19 treatment. Here, we report on the manufacturing of a plasma-based product containing antibodies specific to SARS-CoV-2 obtained from recently recovered COVID-19 pati...

Full description

Bibliographic Details
Main Authors: Viola Hähnel, David Peterhoff, Veronika Bäuerlein, Andreas-Michael Brosig, Irene Pamler, Christian Johnson, Adelina Bica, Monica Totir, Thomas Ossner, Barbara Stemmer, Martina Toelge, Anja Schütz, Hans-Helmut Niller, Barbara Schmidt, Ralf Wagner, André Gessner, Ralph Burkhard, Robert Offner
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2020-01-01
Series:PLoS ONE
Online Access:https://doi.org/10.1371/journal.pone.0243967

Internet

https://doi.org/10.1371/journal.pone.0243967

Similar Items